Announcing Dexcel Pharma USA, formerly known as Edenbridge Pharmaceuticals, LLC.

R

Ethics & Business Conduct

Dexcel Pharma USA readily affirms its commitment to maintaining the highest standards of ethical conduct and strict compliance with the guidelines, rules, and regulations that govern our business practices. Our core values – integrity, ethical behavior, commitment to quality, and professionalism – demonstrate our pledge to excel in every aspect of our business.

As part of this commitment, Dexcel Pharma USA has established certain principles designed to guide employees and business partners in their business-related actions to avoid potential misconduct, including a complete ban on exerting any kind of bribery or improper influence in any type of business transaction.

Additionally, Dexcel Pharma USA recognizes that human trafficking is a serious crime and a grave violation of human rights, and has adopted policies to combat human trafficking in its supply chain, including requiring the inclusion of an appropriate anti-human trafficking clause in all relevant supply chain agreements.

Dexcel Pharma USA expects all of its employees and business partners to conduct themselves in compliance with both their legal and ethical responsibilities in all daily business operations. Dexcel Pharma USA is unreservedly committed to the foregoing and will forgo any business transactions that would violate it.

Dexcel Pharma USA’s Risk Assessment Committee will periodically assess the group’s effectiveness in ensuring that bribery and human trafficking are not taking place in its business or supply chains.

We look forward to working with our business partners in a manner which will allow us to demonstrate our commitment to our principles of ethical behavior and our record as an excellent corporate citizen.